United States· US:63090-660_84ddc48a-cf66-46c9-a673-f0aa23ce8e03
Daybue
A trofinetide product containing trofinetide, registered in United States by Acadia Pharmaceuticals Inc.. The same ATC class is registered in 7 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Trofinetide is registered in 7 of 19 countries.
Countries holding a registration under ATC N07XX24 (trofinetide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Trofinetide · ATC N07XX24
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TROFINETIDE
- Manufacturer
- Acadia Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- N07XX24
- ATC class
- Trofinetide
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 6, 2026
Packs & prices · 1
- ndc1163090-660-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trofinetide in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumDaybu 200 mg/mlAcadia Pharmaceuticals (Netherlands)
- CzechiaDAYBUAcadia Pharmaceuticals (Netherlands) B.V., Amsterdam
- FinlandDaybuAcadia Pharmaceuticals (Netherlands) B.V.
- PolandDaybuAcadia Pharmaceuticals (Netherlands) B.V.
- SwedenDaybu 200 mg/ml Oral lösningAcadia Pharmaceuticals (Netherlands) B.V.
- CanadaDAYBUEACADIA PHARMACEUTICALS INC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/89cab801-56bb-46d7-be56-580ad0d5946d GET /v1/drugs/89cab801-56bb-46d7-be56-580ad0d5946d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "200",
"substance": "TROFINETIDE",
"productndc": "63090-660",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA217026",
"marketing_category": "NDA"
}See everything about trofinetide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.